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Abstract
Background: Dysfunction of vascular endothelium is implicated in many pathological situations. Cytoskeleton plays an
importance role in vascular endothelial permeability barrier and inflammatory response. Many Chinese herbs have the
endothelial protective effect, of which, “Astragalus membranaceus” is a highly valued herb for treatment of cardiovascular
and renal diseases in traditional Chinese medicine, In this study, we tested whether calycosin-7-O-β-D-glucoside
(Calycosin), a main effective monomer component of “Astragalus membranaceus”, could protect endothelial cells from
bacterial endotoxin (LPS)-induced cell injury.
Methods: Endothelial cell injury was induced by exposing human umbilical vein endothelial cells (HUVECs) to LPS. The
effects of calycosin on LPS-induced changes in cell viability, apoptosis rate, cell migration, nitric oxide synthase (NOS),
generationof intracellular reactive oxygen species (ROS) and cytoskeleton organization were determined. Microarray
assay was employed to screen the possible gene expression change. Based on the results of microarray assay, the
expression profile of genes involved in Rho/ROCK pathway and AKT pathway were further evaluated with quantitative
real-time RT-PCR or western blot methods.
Results: Calycosin improved cell viability, suppressed apoptosis and protected the cells from LPS-induced reduction in
cell migration and generation of ROS, protein level of NOS at a comparable magnitude to that of Y27632 and valsartan.
Similar to Y27632 and valsartan, Calycosin, also neutralized LPS-induced actomyosin contraction and vinculin protein
aggregation. Microarray assay, real-time PCR and western blot results revealed that LPS induced expression of FN, ITG
A5, RhoA, PI3K (or PIP2 in western blotting), FAK, VEGF and VEGF R2, and inhibited expression of MLCP. We believed
multiple pathways involved in the regulation of calycosin on HUVECs. Calycosin are considered to be able to activate
MLCP through promoting the generation of NO, decreasing PMLC, suppressing the cytoskeleton remodeling caused
by activation of Rho/ROCK pathway and inhibiting AKT pathway by decreasing VEGF, VEGF R2 and PI3K level.
Conclusion: Calycosin protected HUVEC from LPS-induced endothelial injury, possibly through suppression of Rho/
ROCK pathway and regulation of AKT pathway.
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Background
Endothelial dysfunction is a critical element in the
pathogenesis of hypertension, atherosclerosis, chronic
kidney disease and their complications [1]. The disrup-
tion of semipermeable barrier of endothelial cell (EC)
during inflammatory states causes extravasation of endo-
vascular liquid, tissue edema, thrombosis and aggravated
atherosclerosis [2]. Cytoskeleton plays a central role in
maintaining the integrity of endothelial structure, vascu-
lar permeability barrier and cell signaling transduction.
The endothelial cytoskeleton damage has been reported
in various pathologic situations, including inflammation,
oxidative stress and abnormal hemodynamics.
Bacterial endotoxin (LPS), one of the major proinflam-
matory constituents of the cell walls of gram-negative
bacteria, induces inflammatory processes, oxidative
stress and production of cytokines. LPS activates vascu-
lar endothelial cells and induces leukocyte infiltration
within the vascular wall and promote vascular perme-
ability [3]. Currently, the signaling mechanisms involved
in these actions of LPS are still incompletely understood.
Although endothelial cells of different sources are het-
erogeneous, human umbilical vein endothelial cells
(HUVECs) are shown to respond to LPS and are exten-
sively used for exploration of the mechanism implicated
in endothelial cell injury [4].
Calycosin-7-O-β-D-glucoside (Calycosin) is a main ef-
fective monomer component of Chinese herb “Astragalus
membranaceus”, a highly valued herb used in traditional
Chinese medicine to treat cardiovascular and renal diseases
[5]. Astragalus membranaceus has been proved to improve
immune function, diuresis, and anti-hypertension, anti-
aging, anti-stress and broad spectrum antibacterial effect
[6, 7]. At present, our understanding about the therapeutic
mechanisms of Astragalus membranaceus or calycosin is
still limited. In this study, we examined the potential
protective effect and mechanism of calycosin on LPS-




Human umbilical vein endothelial cells (HUVECs,
ScienCell, USA) were cultured in endothelial cell
medium (ECM, ScienCell, USA) with 5 % FBS. The
3rd-8th passage cells were used in the experiments.
HUVECs were preincubated for 30 min with the 10 μg/ml
calycosin-7-O-β-D-glucoside (Tauto biotech Co. Ltd., #
20633-67-4, Shanghai, China), and 10−5 mol/l valsartan
(Novartis Pharma Ltd., #H20040217, Beijing, China) sep-
arately. And then the inflammatory and injured endothe-
lial model was established by incubating with 0.2 μg/ml
LPS (Sigma, USA) for 24 h. The HUVECs of antagonist
group were treated with 50 μmol/l Y27632 (Sigma, USA),
a popular Rho-associated kinase inhibitor, for 30 min.
Cell viability and apoptosis assays
Cellular viability was determined by an MTT assay; the
cells (2,000/200 μl per well) were plated in sextuplicate
batches in 96-well plates and incubated in different
drugs as indicated, or serum-free M199 (negative con-
trol) or complete ECM (positive control); the cells were
then treated with MTT for 4 h. The resulting absorbance
was measured at 492 nm, with 630 nm as a reference
wavelength. The cell viability rate (%) = (OD value of
experimental group-OD value of negative control group/
OD value of positive control group-OD value of negative
control group) × 100. For the apoptosis treatment, the
HUVECs were treated with drugs and then trypsinized
and collected. The cells (2 × 105) were washed with ice-
cold PBS, incubated with Annexin V (BestBio, Shanghai,
China) and PI (BestBio, Shanghai, China) and analyzed
by flow cytometry.
Content of NOS and NO in the supernatant by nitrate
reductase method
NO, a small molecular substance, participates in the
regulation of oxidative stress and acts as intercellular
messenger molecule to participating in the regulation of
a variety of physiological processes such as angiogenesis,
nerve conduction and memory [8]. Since the biological
half-life of NO is only 3–5 seconds, studies generally
focus on nitrogen oxide synthase (NOS). NOS includes
constructive NOS (cNOS) which is physical form de-
pending on calcium ion and calmodulin, and calcium-
independent inducible NOS (iNOS) which expresses and
activates only when cells are stimulated and produces
large amount of NO recklessly once being activated
causing cell injury, even to death [9].
The content of cNOS in the supernatant was assayed
firstly after HUVECs were incubated with calycosin in
different concentration (0 μg/ml, 0.01 μg/ml, 0.1 μg/ml,
1 μg/ml, 10 μg/ml or 20 μg/ml, all for 24 h of incuba-
tion) or different time (all in 10 μg/ml, 0 h, 4 h, 8 h,
12 h, 24 h or 48 h) separately. In the following study,
HUVECs were preincubated for 30 min with the 10 μg/ml
calycosin and 10−5 mol/l valsartan separately. And then
0.2 μg/ml LPS was added in for 24 h. The HUVECs of
antagonist group were treated with 50 μmol/l Y27632 for
30 min.
After incubation, the content of cNOS and iNOS in
the supernatant was determined by a commercial assay
kit (JianCheng bioengineering institute, #A014-1, Nanjing,
China) and NO in the supernatant was determined by
commercial nitrate reductase method kits (JianCheng bio-
engineering institute, #A012, Nanjing, China). The optical
densities at 540 nm wave length were recorded using a
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Micro-plate Reader (Thermo Multiskan Go, Thermo
Scientific, Waltham, MA, USA) and the concentrations of
cNOS, iNOS and NO were calculated according to the
standard curve.
All samples were assayed in triplicate.
Assessment of intracellular reactive oxygen species (ROS)
generation
HUVECs were cultured in 6-well plates and incubated
in different drugs for 2 h. Cells in 6-well plates were
loaded with fluorescent probe 2’,7’-dichlorofluorescin
diacetate (DCFH-DA, 10 μmol/l, Beyotime Institute of
Biotechnology, S0033, Haimen, China) at 37 °C for
30 min and washed 3 times with PBS to avoid high back-
ground fluorescence, and then observed under Zeiss
Vert A1 fluorescence microscope. Meanwhile, the other
HUVECs were harvested washed with calcium- and
magnesium-free PBS (pH 7.4), and loaded with 10 μmol/l
DCFH-DA at 37 °C for 30 min and washed 3 times with
PBS [5]. Fluorescence was measured using a flow cyt-
ometer (BD Accuri C6, USA); excitation was read at
488 nm and emission was detected at 525 nm. Relative
ROS production was expressed as the percentage of fluor-
escence for the treated samples over fluorescence for the
appropriate controls: (fluorescence treatment/fluorescence
control) × 100.
Transwell insert cell migration assay
The cell migration assay was performed with a Transwell
insert system (6.5 mm diameter inserts with 8.0 μm
pores in a polycarbonate membrane situated in wells of
24 well polystrene, tissue culture-treated plates, Corning,
Lot #21212046, USA). The Transwell inserts were pre-
coated with matrigel (1:8) 4 °C overnight and hydrated
with RPMI 1640 in 37 °C, 5 % CO2 incubator for
30 min. HUVECs suspension was added at 20,000 cells
per insert. Drugs were added to the Transwell inserts as
usual, and ECM in the lower chamber. At the end of this
period, cells on the upper surface of the insert were re-
moved, and migrated cells on the bottom side were fixed
in absolute ethyl alcohol and stained with hematoxylin-
eosin (HE) staining. The filter inserts were removed
from the wells and mounted on glass slides. Cells were
counted from four random fields observed with a 10X
objective lens. The cell migration experiments were re-
peated three times [10].
Immunofluorescence assay for cytoskeleton remodeling
and vinculin expression
Confluent HUVEC monolayers grown on glass cover-
slips were treated with drugs as usual. The monolayers
were then washed with PBS, fixed in 10 % formalin solu-
tion neutral buffered for 30 min, washed twice, and in-
cubated in PBS-5 % BSA for 1 h. Incubation with
primary antibody (anti-vinculin, 1:300, Bioss, Beijing,
China) for overnight at 4 °C. Cover slips were washed in
PBS for 4 times and subsequently incubated with FITC-
conjugated goat anti-rabbit IgG secondary antibody
(1:100), and another antibody (anti-Rhodamine Phalloides,
1:140, Cytoskeleton Inc., USA), and DAPI (0.5 mg/ml) for
5 min at room temperature. Immunofluorescence analysis
was performed on a Leica DC-300F microscope.
Microarray analysis
HUVECs were seeded in 6-well plate, intervened with
drugs, and total RNA was isolated using the TRIzol
method and then reverse transcribed into cDNA with the
PrimeScript RT reagent kit (RR047A, TaKaRa, Dalian,
China). After quantitative detection, cDNA were hybri-
dizated on Affymetrix Hybridization Oven 640. After elu-
tion in the cleaning workstation (GeneChip Fluidics
Station450, Affymetrix), chips were scanned with Gene
Array Scanner3000 7G (Affymetrix) to trace detection
signal. GeneSpring GX 7.3.1 was used for the gene expres-
sion analysis. Transcripts with low expression levels
(<25 % of the median gene expression value) and with fre-
quent miss hybridizations (> 2 absent Flags among the
samples) were not analyzed further. Transcripts that
showed a > 2-fold reduction in expression in HUVECs of
LPS + calycosin group compared with LPS induced
HUVECs were extracted. The transcript list contained 84
transcripts. Both the test group and the control group did
three biological replicates [11].
Real-time PCR
According to the results of the microarray analysis, key
genes (fibronectin(FN), integrin A5(ITG A5), vascular
endothelial growth factor (VEGF), vascular endothelial
growth factor receptor 2 (VEGFR2), Ras homolog gene
family member A (RhoA), myosin light chain phosphata-
se(MLCP), phosphatidylinositol-4,5-bisphosphate 3-kinase
(PI3K), focal adhesion kinase (FAK)) were chosen for
quantitative real-time PCR (qRT-PCR) to verify the gene
expression results. The specific forward/reverse primer
sequences (Sangon Biotech, Shanghai, China) were: FN
(5’-CGAGGAGAGTGGAAGTGTGAG-3’/ 5’-GAGGCTG
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β-actin (5’-AGCGAGCATCCCCCAAAGTT-3’/ 5’-GGGC
ACGAAGGCTCATCATT-3’). Total RNA was isolated
using the TRIzol method and reverse transcribed into
cDNA with the PrimeScript RT reagent kit. Real-time PCR
was carried out using the SYBR Premix Ex Taq kit
(RR420A, TaKaRa, Dalian, China). The reaction mixture
contained SYBR Green Premix Ex Taq, cDNA, and the for-
ward/ reverse primers. Reaction mixture and amplification
conditions were maintained according to the manufactur-
er's instructions. Each RNA was tested in triplicate, and
Fig. 1 Cell viability and apoptosis. Cell viability was determined by MTT assay (b), and the apoptosis rate was determined with Annexin V-FITC/PI
by flow cytometry (a and c). △P < 0.05, compared with normal HUVECs; ★P < 0.05, compared with LPS-induced inflammatory and injured HUVECs
Fig. 2 The content of cNOS, tNOS, iNOS and NO in cell supernatants. The content of cNOS, tNOS, iNOS and NO in cell supernatants was determined by
nitrate reductase method. a The content of cNOS in the supernatant was assayed after HUVECs were incubated with calycosin in different concentration
(0 μg/ml, 0.01 μg/ml, 0.1 μg/ml, 1 μg/ml, 10 μg/ml or 20 μg/ml) for 24 h; b The content of cNOS in the supernatant was assayed after HUVECs were
incubated with 10 μg/ml calycosin for different time (0 h, 4 h, 8 h, 12 h, 24 h or 48 h); c The content of cNOS, tNOS and iNOS in cell supernatants; d The
content of NO in cell supernatants. △P < 0.05, compared with normal HUVECs; ★P < 0.05, compared with LPS-induced inflammatory and injured HUVECs
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the threshold cycle values were normalized to β-actin and
averaged ± SD. The relative gene expression (fold change)
among untreated, LPS, LPS + calycosin, LPS + Y27632 and
LPS + valsartan groups was calculated with the 2^−ΔΔCT
method [12, 13].
Western blotting analysis
The protein expression level of ITG A5, RhoA, PIP2 and
PMLC were determined using Western blotting analysis.
In detail, HUVECs were pre-treated with drugs, and
trypsinized and collected. The cells were washed twice
Fig. 3 Generationof intracellular reactive oxygen species (ROS). a The generation of intracellular ROS was stained by DCFH-DA and observed under Zeiss
Vert A1 fluorescence microscope. b The quantity of production of intracellular ROS was measured using DCFH-DA by flowcytometry. △P < 0.05, compared
with normal HUVECs; ★P < 0.05, compared with LPS-induced inflammatory and injured HUVECs
Fig. 4 Effect of Calycosin on LPS-induced dysfunction of cell migration. a HE staining of migrated HUVECs. Cells were treated with 0.2 μg/ml LPS in the
presence of 10 μg/ml Calycosin, or 50 umol/l Y27632, or10−5 mol/l valsartan for 0.5 h. After that, the migrated cells on the bottom side were stained with
HE staining for counting migrated cells with a 10X objective lens, and cell morphology was photographed. b The amount of migrated cells. △P < 0.05,
compared with normal HUVECs; ★P < 0.05, compared with LPS-induced inflammatory and injured HUVECs
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with 0.1 mol/L PBS and then lysed in RIPA lysis buf-
fer (Beyotime, Nantong, China). The protein concen-
tration of the lysate was determined using a BCA
protein assay kit (Beyotime, Nantong, China). Cell ly-
sates containing 30 μg of protein were subjected to
sodium dodecyl sulfate polyacrylamide gel electro-
phoresis using 12 % polyacrylamide resolving gels.
After electrophoresis, the proteins were transferred
onto PVDF membranes, which were then blocked
with 5 % nonfat dry milk in PBS-0.05 % Tween-20
(PBS-T) for 1 h at room temperature, and incubated
at 4 °C with gentle shaking overnight with primary
antibodies (rabbit anti-human ITG A5, 1:1000,
Abgent, San Diego, USA; rabbit anti-human RhoA,
1:400, Bioss, Beijing, China; mouse anti-human PIP2,
1:800, Santa Cruz, USA; and rabbit anti-human
PMLC, 1:400, Bioss, Beijing, China) . After washed
with PBS-T, the blots were incubated with horseradish
peroxidase conjugated to goat anti-rabbit IgG
(1:20,000) for 1 h. They were then incubated with
0.5 mL ECL chemiluminescence reagent and exposed
for 30 s under LAS4000. The optical density of the
protein of interest relative to that of β-actin was ana-
lyzed by Image J.
Statistics
Statistical analyses were performed using SPSS 19.0.
Values were presented as mean ± SD. Unless stated, statis-
tical comparisons were made using two-factor analysis of
variance (ANOVA). P-values less than 0.05 were consid-
ered significant.
Results
Cell viability and apoptosis
The cell viability decreased (6.9 %), and the apoptosis
rate increased (3.5-fold) after treating the HUVECs
with LPS for 24 h. All of the drugs improved cell
viability and suppressed apoptosis. Calycosin demon-
strated the best efficacy for suppressing apoptosis,
and valsartan demonstrated the best efficacy for
improving cell viability. (Fig. 1)
Content of NOS and NO in the supernatant
HUVECs demonstrated eminent dose dependent and time
dependent changes in the content of cNOS with the
change of calycosin. HUVECs generated the highest cNOS
level after incubation with 10 μg/ml calycosin for 24 h
(Fig. 2 a and b). After treatment of HUVECs with LPS for
Fig. 5 Effect of Calycosin on LPS-induced disorganization of cytoskeleton andmorphological change of vinculin. Immunofluorescence assay was performed
with phalloidin and anti-vinculin antibody. Cells were fixed and stained for F-actin to observe cytoskeleton remodeling (red), vinculin (green) andmerged
images are shown in yellowwhichmeans that Rho/ROCK pathwaywas activated. Scale bar = 25 μm
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24 h, the level of cNOS was decreased, whereas iNOS and
its product NO in the culture supernatant were elevated,
indicating inflammatory endothelial activation. Calycosin
intervention significantly increased cellular cNOS level,
whereas it suppressed iNOS (P < 0.05, Fig. 2 c and d).
These observations indicate Calycosin effectively alleviated
the inflammatory endothelial injury. Interestingly, the over-
all concentration of NO was increased, which might be
caused by the elevated cNOS level. Y27632 also increased
the levels of cNOS and tNOS significantly (P < 0.05), but it
had little effect on iNOS and NO. Valsartan effectively
reduced iNOS and NO level (P < 0.05), but it failed to affect
cNOS and tNOS.
Generationof intracellular reactive oxygen species (ROS)
LPS increased ROS generation significantly (P < 0.05,
from 6.64±0.37 % to 13.47±1.46 %). Calycosin, valsartan
and Y27632 effectively inhibited the ROS generation of
HUVECs (P < 0.05) (Fig. 3).
Calycosin counteracts the inhibitory effects of LPS on
endothelial migration
As shown in Fig. 4, treatment of HUVECs with LPS for
24 h suppressed their migratory capability. The number of
migrated cells on the bottom side of transwell insert was
significantly reduced (P < 0.05). HE staining revealed that
LPS-treated HUVECs were in poor state. The number of
the shrunken/smaller cells was obviously increased. In the
presence of calycosin, Y27632 or valsartan, however, this
effect of LPS was greatly blunted (P > 0.05). Calycosin
demonstrated the most potent protective effect among
these three drugs.
Calycosin protects endothelial cells from LPS-induced
disorganization of cytoskeleton and vinculin
Normally, cytoskeletal protein fibrous-actin (F-actin)
was arranged circularly around the subapical region of
HUVECs; vinculin protein was evenly localized at cell-
to-cell contact region. However LPS treatment led to cell
shrinkage. F-actin and vinculin were found to be con-
densed aggregates. The results suggested that LPS acti-
vated the endothelial cells and induced actomyosin
contraction. In the presence of calycosin or Y27632,
these changes were largely prevented (Fig. 5). It was also
prevented by valsartan.
Effect of calycosin on gene and protein expresses of HUVECs
induced by LPS
Then we explored the protective mechanism of calycosin
on vascular endothelium. PCR microarray was employed
to screen the genes that might be involved in remolding
of endothelial structure and function. The results were
listed in Table 1.
According to the findings from microarray, we per-
formed quantitative real-time RT-PCR (Fig. 6) and west-
ern blotting (Fig. 7) analysis. LPS indeed increased the
mRNA expression of FN, ITG A5, RhoA, PI3K FAK,
VEGF and VEGFR2, and decreased the mRNA expres-
sion of MLCP, indicating an activation of Rho/ROCK
pathway. This activation was blocked by Y27632 and val-
sartan. After treatment with calycosin, FN, ITG A5, VEGF,
VEGF R2, PI3K and FAK were significantly decreased,
while MLCP was significantly increased (P < 0.05); as for
RhoA, calycosin only slightly elevated its levels (P > 0.05)
(Fig. 6). Consistent with the elevated mRNA expression,
the protein expression of ITG A5, PIP2, RhoA and PMLC
was also elevated in LPS-induced HUVECs, which was
suppressed by Y27632 or valsartan. Whereas, RhoA
(Fig. 7a) were decreased slightly, and, ITG A5 (Fig. 7b),
PIP2 (Fig. 7c) and PMLC (Fig. 7d) was decreased after
intervention with calycosin.
Discussion and conclusions
The integrity of endothelial barrier is important for the
maintenance of normal endothelial structure and function.
Dysfunction of endothelial barrier has been implicated in
various pathological situations [14–16]. Regulation of the
endothelial cell (EC) barrier is achieved via the balance be-
tween actomyosin-driven contractile events and tethering
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forces implied by cell adhesive structures and the cortical
actin cytoskeletal network [17]. Cells respond to external
stimuli by altering dynamics of microtubule assembly/dis-
assembly and spatial rearrangements. Conversely, changes
in microtubule dynamics modulate intracellular signal
transduction [18]. In the present study, LPS induced
HUVECs to the state of inflammation and oxidative stress,
the decrease of content of cNOS and generation of iNO,
ROS and cell migration rate. We assumed all these
changes may be due to the remodeling of cytoskeleton.
After LPS treatment for 24 h, the cell morphology and size
changed dramatically. Cytoskeletal proteins, F-actin and
vinculin, were detected as condensed aggregates. Activa-
tion of endothelium by LPS induced actomyosin contrac-
tion, resulting in the opening of intercellular gaps, which
might lead to the increased endothelium permeability, de-
creased migratory capability and enhanced transmigration
of leukocytes. All the changes were almost completely
normalized by calycosin. The results suggest Calycosin
protected HUVECs from LPS-induced decreased gener-
ation capability of iNO, ROS and cell migration through
regulation the cytoskeletal structure and function.
Cell cytoskeleton is also involved in the regulation of
cell viability and apoptosis. According to the results of
Fig. 6 Effect of Calycosin on LPS-induced the change of gene expresses induced by LPS. Results of up- or down-regulated molecules in micro-
array (a) and quantitive real-time RT-PCR (b). △P < 0.05, compared with normal HUVECs; ★P < 0.05, compared with LPS-induced inflammatory and
injured HUVECs
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MTT and Annexin V-FITC/PI in this study, after LPS
treatment for 24 h, the cytoskeleton was activated, apop-
tosis related enzymes or proteins, such as caspase, gelsin
focal adhesion kinase and their downstream pathways
was activated. Thereafter, DNA and nuclear structure
was damaged, the signals to be engulfed were expressed
highly, and degraded into the apoptotic bodies in the
end. Accompanied with the increased apoptosis rate in-
duced by LPS, the cytoskeleton shrinkaged and contracted.
Calycosin demonstrated protective effect to regulate the
distribution of actin cytoskeleton and vinculin effectively,
simultaneously, reduced the apoptosis rate. This implies
that the stabilization of endothelial cells might be one of
the cellular mechanisms by which Calycosin alleviates
hypertension and chronic kidney disease.
Rho, as a molecular switch in cell signal transduction
pathway, cycling between the biologically active GTP-
bound form and the inactive GDP-bound state, controls a
wide variety of cellular processes [19, 20]. Rho-kinase
(ROCK), identified as a downstream target of Rho A, reg-
ulates on endothelial permeability mainly via the actin
cytoskeleton formation and contractility implementation.
The activation of Rho/ROCK induces the rearrangements
of actin cytoskeleton and stress fiber formation [21]. The
activation of Rho/ROCK pathway promotes monocyte
chemotaxis, endothelial permeability dysfunction and ele-
vates the expression of plasminogen activator inhibitor -1
(PAI-1), thus facilitating the pathologies of atherosclerosis
and other diseases [22, 23]. Meanwhile, ROCK decreases
the expression of cNOS and promotes the expression of
cytokines of inflammation, oxidative stress, thrombosis
and fibrosis. CNOS plays an important role in the regula-
tion of vasodilation, inhibition of platelet aggregation and
withstand leukocyte adhesive to the vascular wall [24].
ROCK phosphorylates and activates MYPT-1 and LIM
kinase 1, causing microtubule decomposition and barrier
damage [25, 26]. The RhoA/ROCK signaling pathway is
also involved in the regulation of sphingosine, cytokine,
shear stress and other factors on the formation of actin
cytoskeleton and promotion endothelial cell migration
[27].
Since the changes in cell migration and cytoskeletal struc-
ture were significant in this study, we had initially specu-
lated that RhoA was target of calycosin. But the results of
both microarray and quantitative PCR denied it. We noted
that calycosin increased cNOS, tNOS and NO levels in
HUVECs significantly and suppressed harmful iNOS. NO
not only has the direct vasodilation, inhibition the
Fig. 7 Effects of Calycosin on LPS-induced the change of protein expresses of RhoA (a), ITG A5 (b), PIP2 (c) and PMLC (d). Cells were
treated with 0.2 μg/ml LPS in the presence of 10 μg/ml Calycosin, or 50umol/l Y27632, or10−5 mol/l valsartan for 0.5 h. Cellular lysates
were extracted and subjected to Western blot analysis of RhoA, ITG A5, PIP2 and PMLC. △P < 0.05, compared with normal HUVECs;
★P < 0.05, compared with LPS-induced inflammatory and injured HUVECs
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activation of cell skeleton and protective effect on vascular
endothelial cells, but also because NO activates myosin
light chain phosphorylase (MLCP), which dephosphorylates
and decreases PMLC, inhibit myosin aggregation and dem-
onstrate the indirect effect against the vasoconstriction
induced by ROCK [28]. Calycosin activated MLCP signifi-
cantly which dephosphorylated and down-regulated the
expression of PMLC, causing the inhibition of myosin
aggregation and cytoskeletal contraction directly. So, it was
concluded that calycosin influenced Rho/ROCK pathway
through regulating the expression of NO, FN, ITG A5,
MLCP and PMLC.
Phosphatidylinositol 3-kinase (PI3K) and the down-
stream serine/threonine kinase Akt/protein kinase B are
involved in the signaling cascade to mediate cell migration
[29]. Recently, the cross-talking between Rho/ROCK path-
way and Akt pathway has drawn considerable attention
for its involvement in cardiovascular diseases such as
hypertension, vasospastic angina, ischemic stroke, heart
failure, atherosclerosis and various cancer cells [3, 30].
AKT being actived by PIP3, promotes the generation of
cNOS and NO [31]. Because the Rho/ROCK pathway and
AKT pathway have a common substrate PIP2 and a com-
mon kinase PI3K, the two pathways adjust and regulate
mutually and demonstrate coordination effect. PIP2 and
PI3K are involved in cross-talking of multiple signaling
pathways and regulate complicated cell process.
In the present study, we observed that effect of calyco-
sin on gene and protein expresses of HUVECs induced
by LPS. LPS activated the Rho/ROCK pathway, leading
to F-actin disorganization and endothelial barrier dys-
function. Given that Rho/ROCK pathway controls cell
structure and function, the protective effect of calycosin
was most likely due to its effect on this pathway. Y27632
and valsartan effectively blocked the activation of Rho/
ROCK pathway. The genes and proteins expressed re-
lated to Rho/ROCK pathway were all suppressed after
treatment with Y27632 and valsartan. FN, ITG A5,
VEGF, VEGF R2, PI3K and FAK were decreased, while
MLCP was increased; as for RhoA, calycosin only
slightly elevated its levels, suggesting that calycosin plays
its role more than Rho/ROCK pathway. Meanwhile,
calycosin regulated other pathway (such as AKT path-
way) by influencing the expression of VEGF and VEGF
R2 and PI3K. VEGF, VEGF R2, PI3K, FAK expression de-
creased after calycosin treatment, suggesting that calycosin
protected HUVECs by inhibiting other pathways and we
thought AKT pathway was involved in the procession and
calycosin suppressed AKT pathway through decrease of
VEGF, VEGF R2 and PI3K. We thought calycosin pro-
tected vascular endothelium and improved the cytoskel-
eton reconstruction by inhibition the AKT pathway,
increase cNOS and NO, decrease iNOS and PMLC and
inhibition myosin aggregation and angiogenesis.
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